Developing biomarker-based tools for cancer screening, diagnosis, and treatment : the state of the science, evaluation, implementation, and economics : workshop summary /
Clasificación: | Libro Electrónico |
---|---|
Autor principal: | |
Autores Corporativos: | , |
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Washington, D.C. :
National Academies Press,
©2006.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover
- Reviewers
- Contents
- Introduction
- Overview of Technologies Used to Discover Cancer Biomarkers
- Genomics, Proteomics, and Metabolomics
- Molecular Imaging
- Meeting the Technical Challenges of Biomarker Validation and Qualification
- Coordinating the Development of Biomarkers and Targeted Therapies
- Therapeutics Industry Perspective
- Diagnostics Industry Perspective
- NCI Perspective
- Clinical Investigator Perspective
- Biomarker Development and Regulatory Oversight
- FDA Critical Path Initiative
- Oversight of Diagnostic Tests
- Designing Clinical Studies of Biomarkers
- Assessment and Adoption of Biomarker-Based Technologies
- Federal Programs for Technology Assessment
- Insurance Coverage Decisions and Practice Guidelines
- CMS Coverage of Biomarkers
- Economic Impact of Biomarkers
- Cost-Effectiveness Analysis
- The Value of Information and Research
- Technology Assessment in the Private Sector
- Clinical Development Strategies for Biomarker Utilization Discussion
- Strategies for Implementing Standardized Biorepositories Discussion
- Strategies for Determining Analytic Validity and Clinical Utility of Biomarkers Discussion
- Strategies to Develop Biomarkers for Early Detection Discussion
- Mechanisms for Developing an Evidence Base Discussion
- Evaluation of Evidence in Decision Making Discussion
- Incorporating Biomarker Evidence Into Clinical Practice Discussion
- Acronyms
- Glossary
- References
- Appendixes
- Appendix A Workshop Agenda
- Appendix B Workshop Speakers, Moderators, Invited Discussants, and Participants
- Last Page.